Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
202.60
Ask:
203.00
Spread: 0.40 (0.197%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jan 2018 07:00

RNS Number : 9411B
Ashmore Group PLC
16 January 2018
 

Ashmore Group plc+0700 16 January 2018

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2017.

Assets under management

Theme

Actual30 September 2017

(US$ billion)

Estimated31 December 2017

(US$ billion)

Movement

(%)

External debt

14.4

15.0

+4%

Local currency

12.7

14.9

+17%

Corporate debt

6.9

7.8

+13%

Blended debt

18.8

18.8

-

Equities

3.5

3.9

+11%

Alternatives

1.6

1.6

-

Multi-asset

1.1

1.2

+9%

Overlay / liquidity

6.0

6.3

+5%

Total

65.0

69.5

+7%

 

Assets under management increased by US$4.5 billion during the period, with net inflows of US$3.6 billion and positive investment performance of US$0.9 billion.

The continued strong net inflows in the quarter are consistent with this stage in the cycle as investors appreciate the high returns available and look to address underweight positions. Gross subscriptions increased from a broad range of clients, including both additional allocations from existing investors and new mandates. Net inflows were particularly strong in the local currency theme as investors are now recognising the significant value available. Net inflows were also delivered in the corporate debt, overlay/liquidity, equities and external debt themes. Net flows were broadly flat in the blended debt, alternatives and multi-asset themes.

Ashmore delivered positive absolute performance in the quarter across both fixed income and equities product ranges while performance was flat in alternatives and overlay/liquidity. Relative performance against both benchmarks and the peer group continues to be very strong.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging Markets assets have delivered strong absolute and relative performance over the past two years leading to higher client flows into the Group's funds. Additionally, competitive currencies have been driving exports thus accelerating economic growth across Emerging Markets. The next phase of the cycle should see institutional flows stimulating domestic demand and so provide for continued attractive returns, particularly from local currency-denominated assets including equities. Our 2018 outlook is for another year of outperformance across the range of Emerging Markets asset classes."

 

Notes

1. For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.3513 at 31 December 2017 (30 June 2017: 1.2946; 31 December 2016: 1.2340). For the translation of US dollar management fees, the average GBP:USD exchange rate achieved for the first half of the financial year was 1.3259 (H1 2016/17: 1.2809).

Ashmore will announce its interim results in respect of the six months ended 31 December 2017 on 8 February 2018.

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingAndrew Walton +44 (0)20 3727 1514Laura Ewart +44 (0)20 3727 1160

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFITLFIELIT
Date   Source Headline
10th Apr 20147:00 amRNSInterim Management Statement
9th Apr 20142:13 pmRNSHolding(s) in Company
8th Apr 20142:47 pmRNSHolding(s) in Company
28th Mar 20145:30 pmRNSDirector/PDMR Shareholding
3rd Mar 20145:48 pmRNSHolding(s) in Company
28th Feb 20147:00 amRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSHalf Yearly Report
24th Feb 20143:14 pmRNSHolding(s) in Company
14th Jan 20147:00 amRNSQ2 AuM Statement
6th Jan 20148:36 amRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSDirectorate Change
30th Oct 20132:51 pmRNSResult of AGM
29th Oct 20135:00 pmRNSAnnual Information Update
21st Oct 201312:03 pmRNSDirector/PDMR Shareholding
10th Oct 20137:00 amRNSInterim Management Statement
30th Sep 20135:08 pmRNSNotice of AGM
18th Sep 20134:40 pmRNSDirector/PDMR Shareholding
18th Sep 20134:36 pmRNSDirector/PDMR Shareholding
10th Sep 20137:00 amRNSFinal Results
2nd Aug 20134:28 pmRNSHolding(s) in Company
11th Jul 20137:00 amRNSQ4 AuM Statement
9th Jul 20135:43 pmRNSHolding(s) in Company
3rd Jul 20135:03 pmRNSDirector/PDMR Shareholding
24th Jun 20136:28 pmRNSHolding(s) in Company
21st Jun 20133:33 pmRNSHolding(s) in Company
17th Jun 20133:25 pmRNSHolding(s) in Company
13th Jun 20134:05 pmRNSHolding(s) in Company
7th Jun 201311:20 amRNSHolding(s) in Company
24th Apr 20137:00 amRNSCapital Markets Day
11th Apr 20137:00 amRNSInterim Management Statement
25th Mar 20134:30 pmRNSDirector/PDMR Shareholding
21st Mar 201311:36 amRNSHolding(s) in Company
22nd Feb 20134:30 pmRNSDirector/PDMR Shareholding
21st Feb 20137:00 amRNSHalf Yearly Report
19th Feb 20132:06 pmRNSAppointment of Directors
4th Dec 20125:30 pmRNSDirector/PDMR Shareholding
31st Oct 20124:38 pmRNSResult of AGM
26th Oct 20128:48 amRNSAnnual Information Update
11th Oct 20127:00 amRNSInterim Management Statement
1st Oct 20124:24 pmRNSNotice of AGM
21st Sep 20124:20 pmRNSDirector/PDMR Shareholding
11th Sep 20127:00 amRNSFinal Results
12th Jul 20127:00 amRNSTrading Statement
12th Apr 20127:00 amRNSInterim Management Statement
30th Mar 20126:01 pmRNSHolding(s) in Company
30th Mar 20126:00 pmRNSDirector/PDMR Shareholding
27th Feb 20125:10 pmRNSHolding(s) in Company
23rd Feb 20127:00 amRNSHalf Yearly Report
16th Feb 20125:58 pmRNSHolding(s) in Company
10th Feb 20127:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.